What Third-Party Testing Actually Means for Research Peptides

In analytical chemistry, a third-party test is one performed by a laboratory that is organizationally and financially independent of the party that made or is selling the material. For research peptides, that usually means the manufacturer sends a lot to an outside lab, which runs the requested assays and issues a report directly to the requester.

Independence removes two structural conflicts of interest: the incentive to overstate purity, and the incentive to under-report impurities that would delay a shipment. It does not replace an in-house COA — the two documents serve different purposes and the best suppliers ship both.

A defensible third-party report always includes:

• The testing laboratory's legal name, address, and contact information.
• The exact lot or batch number of the material submitted.
• The analytical method used, including column chemistry, mobile phases, gradient, flow rate, and detection wavelength for HPLC work.
• The instrument model or class — for example, "Waters ACQUITY UPLC with PDA detector."
• Reported results with units (percent area, m/z, EU/mg, and so on).
• The raw chromatogram or spectrum, embedded or referenced.
• Analyst signature and issue date.

A one-page PDF that reads "Purity: 99.2% — Passed" with no method, no chromatogram, and no lab identifier is a marketing asset, not a report.

• Lot mismatch. The vial ships with lot A but the report shows lot B. The report is not evidence of the vial's contents.
• Recycled reports. The same chromatogram, same date, and same peak times appear under multiple product names. The report was cloned.
• No method details. A number without a method is a claim. It cannot be reproduced or challenged.
• Undated or unsigned. A document of record must be attributable to a named analyst at a named lab on a specific date.
• Non-existent lab. A quick check that the lab's contact information resolves to a real facility is a reasonable due-diligence step.

Third-party testing is one signal among several. It is strongest when combined with lot-level in-house documentation, transparent synthesis and shipping information, and consistent results across lots over time. A single independent report does not certify the next lot; a supplier's practice of publishing independent reports across every lot does.

For a walkthrough of the fields on a report, see How to Read a Peptide COA, or review our testing standards to see what is measured on every lot we release.